Cargando…

The use of machine learning to support the therapeutic process – strengths and weaknesses

PURPOSE: Artificial neural networks, “artificial intelligence” or machine learning now dominate a number of areas, making many activities automatic and thus affecting the safety and comfort of life. Neural networks might provide intelligent decisions with limited human assistance. Medicine also uses...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewanowicz, Adam, Wiśniewski, Maria, Oronowicz-Jaśkowiak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112525/
https://www.ncbi.nlm.nih.gov/pubmed/37081907
http://dx.doi.org/10.5114/ppn.2022.125050
_version_ 1785027640679202816
author Lewanowicz, Adam
Wiśniewski, Maria
Oronowicz-Jaśkowiak, Wojciech
author_facet Lewanowicz, Adam
Wiśniewski, Maria
Oronowicz-Jaśkowiak, Wojciech
author_sort Lewanowicz, Adam
collection PubMed
description PURPOSE: Artificial neural networks, “artificial intelligence” or machine learning now dominate a number of areas, making many activities automatic and thus affecting the safety and comfort of life. Neural networks might provide intelligent decisions with limited human assistance. Medicine also uses artificial intelligence, also in models designed to support the therapeutic process. The aim of this article is to define the main directions of development of machine learning applications in supporting the therapeutic processes. VIEWS: Currently, the literature distinguishes at least a few applications of new technologies of varying degrees of advancement, with machine learning at the forefront [6]. It seems that the researchers are most interested in personalizing notifications of therapeutic applications, modifying therapeutic programs in a manner adapted to the patient’s problems, and conducting “intelligent” conversations with them. CONCLUSIONS: There are dangers in using machine learning methods to support the therapeutic process. Particular attention should be paid to ensuring the full privacy of the implemented applications; moreover, selling user data of this type to third parties, such as those that sell certain medications or dietary supplements, would be ethically questionable. There are no legal regulations (or a system of recommendations of relevant scientific societies) that would limit proven applications to support the therapeutic process of a given disorder in the future, and which were created solely for the financial purpose of authors who did not conduct substantive consultations.
format Online
Article
Text
id pubmed-10112525
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-101125252023-04-19 The use of machine learning to support the therapeutic process – strengths and weaknesses Lewanowicz, Adam Wiśniewski, Maria Oronowicz-Jaśkowiak, Wojciech Postep Psychiatr Neurol Review Article PURPOSE: Artificial neural networks, “artificial intelligence” or machine learning now dominate a number of areas, making many activities automatic and thus affecting the safety and comfort of life. Neural networks might provide intelligent decisions with limited human assistance. Medicine also uses artificial intelligence, also in models designed to support the therapeutic process. The aim of this article is to define the main directions of development of machine learning applications in supporting the therapeutic processes. VIEWS: Currently, the literature distinguishes at least a few applications of new technologies of varying degrees of advancement, with machine learning at the forefront [6]. It seems that the researchers are most interested in personalizing notifications of therapeutic applications, modifying therapeutic programs in a manner adapted to the patient’s problems, and conducting “intelligent” conversations with them. CONCLUSIONS: There are dangers in using machine learning methods to support the therapeutic process. Particular attention should be paid to ensuring the full privacy of the implemented applications; moreover, selling user data of this type to third parties, such as those that sell certain medications or dietary supplements, would be ethically questionable. There are no legal regulations (or a system of recommendations of relevant scientific societies) that would limit proven applications to support the therapeutic process of a given disorder in the future, and which were created solely for the financial purpose of authors who did not conduct substantive consultations. Termedia Publishing House 2023-02-14 2022-12 /pmc/articles/PMC10112525/ /pubmed/37081907 http://dx.doi.org/10.5114/ppn.2022.125050 Text en Copyright © 2022 Institute of Psychiatry and Neurology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review Article
Lewanowicz, Adam
Wiśniewski, Maria
Oronowicz-Jaśkowiak, Wojciech
The use of machine learning to support the therapeutic process – strengths and weaknesses
title The use of machine learning to support the therapeutic process – strengths and weaknesses
title_full The use of machine learning to support the therapeutic process – strengths and weaknesses
title_fullStr The use of machine learning to support the therapeutic process – strengths and weaknesses
title_full_unstemmed The use of machine learning to support the therapeutic process – strengths and weaknesses
title_short The use of machine learning to support the therapeutic process – strengths and weaknesses
title_sort use of machine learning to support the therapeutic process – strengths and weaknesses
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112525/
https://www.ncbi.nlm.nih.gov/pubmed/37081907
http://dx.doi.org/10.5114/ppn.2022.125050
work_keys_str_mv AT lewanowiczadam theuseofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses
AT wisniewskimaria theuseofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses
AT oronowiczjaskowiakwojciech theuseofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses
AT lewanowiczadam useofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses
AT wisniewskimaria useofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses
AT oronowiczjaskowiakwojciech useofmachinelearningtosupportthetherapeuticprocessstrengthsandweaknesses